← feed

Is NCT03826550 results overdue?

Yes — results are overdue. Primary completion was 2018-06-30; the FDAAA-801 reporting deadline (2019-06-30) passed 2594 days ago and no results are posted on ClinicalTrials.gov.

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

NCT IDNCT03826550 ↗
SponsorEncube Ethicals Pvt. Ltd. (INDUSTRY)
PhasePHASE3
StatusCOMPLETED
Primary completion2018-06-30 (ACTUAL)
Reporting deadline2019-06-30 (completion + 365d)
Days overdue2594
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 01376a57815b828f… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03826550. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →